AVE avecho biotechnology limited

the positive side if elixia launch ?fails?, page-6

  1. 379 Posts.
    My point precisely, Karicoum. The business plan depends on a succesful rollout. I hope, as much as anybody else, that succeed it indeed does!

    It's a high risk/high rewards strategy. My musings are if it doesn't. 'Failure' perhaps potentially not as bad as it might at seem first thought, is my simple conclusion.
    The top ten investors will naturally and in the normal business course reappraise their views as events unfold, for good or not so good.

    Enough for today - the weeding calls!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $11.10M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $1.335K 381.5K

Buyers (Bids)

No. Vol. Price($)
44 33957138 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 8218985 6
View Market Depth
Last trade - 11.13am 07/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.